Get your Politiken Edition subscription

Novo Nordisk is taking an unusually calm approach to the news of blockbuster sales of its new pill and the company’s highest revenue ever — and there are good reasons for that.

The Wegovy pill exceeds every expectation. But Novo is holding back its cheers

Mike Doustdar er direktøren, der skal holde Novo Nordisk på ret kurs. Animation og kollage: Tomas Østergren. Foto: Kenneth Lysbjerg Koustrup
Listen to the article

Novo’s new Wegovy pill is selling so well it blows past anything anyone expected.

The weight-loss pill has sold between twice and three times as much compared with what analysts had been guessing.Oversættelsesdisclaimer

This is for subscribers' eyes only

But don’t you worry. Your Politiken Edition subscription is just one click away. We are looking forward to bringing you a handpicked selection of Politiken's stories - translated into English.

Subscribe now
Already a subscriber? Welcome back. Sign in here
Edition 2

Most read

    1

  1. The Wegovy pill exceeds every expectation. But Novo is holding back its cheers

    2. 2

  2. New international train for Danes impresses passenger: »We walk in, and the first thing we see is a bar!«

    3. 3

  3. The U.S. seeks the extradition of a Danish researcher

    4. 4

  4. The chemicals are everywhere: Not a single soil sample from Denmark is clean

    5. 5

  5. Several politicians say the electoral threshold should be raised

    6. 6

  6. Why the family stayed by the railway tracks in Vesterbro

© All material on this page is subject to the applicable copyright law.Read policy